New prognostic histological parameter of invasive ductal carcinoma of the breast: Clinicopathological significance of fibrotic focus

被引:48
作者
Hasebe, T
Mukai, K
Tsuda, H
Ochiai, A
机构
[1] Natl Canc Ctr, Res Inst E, Div Pathol, Chiba 2778577, Japan
[2] Natl Canc Ctr, Res Inst, Div Pathol, Tokyo 104, Japan
[3] Tokyo Med Univ, Dept Pathol 1, Tokyo, Japan
关键词
angiogenesis; breast cancer; fibrotic focus; growth factor; growth factor receptor; histology; invasive ductal carcinoma; prognosis; proliferative activity; tumor grade;
D O I
10.1046/j.1440-1827.2000.01035.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemistry, DNA ploidy analysis and molecular genetics have made it possible to predict the outcome of breast cancer more precisely than routine histological examination alone. However, in routine practice, it is difficult to incorporate these methodologies in all cases. If certain histological parameters can accurately predict the outcome of patients with breast cancer, they would be more practical for routine use. We showed that the presence of fibrotic focus (FF) in invasive ductal carcinoma (IDC) is closely associated with c-erbB-2 or p53 protein expression, high proliferative activity, and high angiogenesis of the tumors. Furthermore, multivariate analyses with well-known prognostic parameters for IDC demonstrated that the presence of FF is the most useful independent parameter to predict IDC patient outcome. In addition, our data suggested that the interaction between tumor cells and stromal fibroblasts may play an important role in the formation of FF in IDC based on growth factor and growth factor receptor protein expression in the tumor cells and fibroblasts forming FF. Based on the results of our clinicopathological studies, we propose a new prognostic classification scheme for the prediction of IDC patient outcome, which consists of FF, nuclear atypia, and fat invasion. This classification has superior predicting power to existing prognostic classifications.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 92 条
  • [1] PROLIFERATING-CELL NUCLEAR ANTIGEN (PC10) IMMUNOLABELING AND OTHER PROLIFERATION INDEXES AS PROGNOSTIC FACTORS IN BREAST-CANCER
    AALTOMAA, S
    LIPPONEN, P
    PAPINAHO, S
    SYRJANEN, K
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (05) : 288 - 294
  • [2] ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO
  • [3] 2-7
  • [4] Ahmad A, 1998, AM J PATHOL, V152, P721
  • [5] Albert R, 1998, LAB INVEST, V78, P247
  • [6] AUER G, 1984, CANCER RES, V44, P394
  • [7] IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS
    BARNES, DM
    DUBLIN, EA
    FISHER, CJ
    LEVISON, DA
    MILLIS, RR
    [J]. HUMAN PATHOLOGY, 1993, 24 (05) : 469 - 476
  • [8] BARNES R, 1991, AM J PATHOL, V139, P245
  • [9] Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO
  • [10] 2-Y